| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |